AstraZeneca, Sun Pharma enter brand partnership to market hyperkalaemia drug
This story was originally published at 17:04 IST on 17 November 2025
Register to read our real-time news.Informist, Monday, Nov. 17, 2025
--AstraZeneca, Sun Pharma partner for Sodium Zirconium Cyclosilicate
MUMBAI – AstraZeneca Pharma India Ltd. and Sun Pharmaceutical Industries Ltd. have entered into a brand partnership to distribute sodium zirconium cyclosilicate powder, which is used to treat hyperkalaemia. AstraZeneca Pharma will retain the drug's intellectual property rights and continue to hold the marketing authorisation and import licence for the molecule, the company said in an exchange filing Monday.
The agreement is aimed at increasing the availability of the drug, AstraZeneca Pharma said. The two companies will promote, market, and distribute the product under different brand names--AstraZeneca Pharma as Lokelma and Sun Pharma as Gimliand.
Hyperkalaemia is a condition in which patients have high potassium levels in their blood. It affects patients with chronic kidney disease and those undergoing treatment for heart failure, as certain therapies can raise potassium levels.
For the September quarter, AstraZeneca Pharma reported a net profit of INR 542.20 million on a revenue of INR 5.59 billion. For the same period, Sun Pharmaceutical reported a consolidated net profit of INR 31.18 billion on a revenue of INR 144.78 billion. Monday, shares of AstraZeneca closed marginally lower at INR 9,140 on the National Stock Exchange while those of Sun Pharmaceutical ended 0.4% higher at INR 1,763.90. End
Reported by Eshitva Prakash
Edited by Subhojit Sarkar
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2025. All rights reserved.
To read more please subscribe
Share this Story:
